
Learn the Open reduction and soft tissue correction of a congenitally dislocated knee surgical technique with step by step instructions on OrthOracle. Our e-learning platform contains high resolution images and a certified CME of the Open reduction and soft tissue correction of a congenitally dislocated knee surgical procedure.
Congenital dislocation of the knee (CDK) is rare occurring in 1 in 100,000 live births. Approximately 50% of cases are associated with other conditions including myelodysplasia, arthrogryposis and Larsen’s syndrome.
The severity of the condition is fairly variable. Milder cases can often be managed with serial casting where as the most severe cases require aggressive lengthening of the quadriceps extensor mechanism and an open release of the knee joint, which is shown in the case detailed here.
Surgery is best performed before 1 year of age and patients with associated syndromes will generally have a poorer prognosis.

INDICATIONS
Congenital dislocation of the knee (CDK) is rare, occurring in 1 in 100,000 live births. This is approximately 1ooth the incidence of developmental dysplasia of the hip (DDH). Half of patients have neuromuscular or musculoskeletal pathologies, the most common being myelodysplasia, arthrogryposis and Larsen’s syndrome.
SYMPTOMS & EXAMINATION
Patients with CDK are generally identified at birth. They present with a hyperextended knee (often up to 90 degrees) such that the foot is frequently in close proximity to the face. Frequently associated abnormalities include Developmental dysplasia of the hip (DDH) and congenital talipes equinovarus (CTEV). These occur in 40-50% of cases. Sixty percent of cases of CDK are bilateral.
Early examination (first 24 hrs) is useful in deciding on treatment strategy. The Tarek classification is determined by the amount of passive knee flexion that is possible:
Grade I: Knees will allow passive flexion of the knee to 90 degrees (recurvatum).
Grade II: Knees will allow 30-90 degrees passive flexion (generally these knees will be subluxed).
Grade III: Knees have less than 30 degrees passive flexion. These are generally the true dislocations with no contact between the tibial plateau and the femoral condyles.
IMAGING
Hip ultrasound is mandatory to rule out DDH. Ultrasound of the knee is also useful since it will help to determine whether the knee is truly dislocated (in which case the tibia lies in front of the femur), subluxed, or simply hyper extended (recurvatum). X ray can also be helpful although much of the knee is unossified in the new born period.
ALTERNATIVE OPERATIVE TREATMENT
The most severe (gradeIII) knees may still be trialed with serial casting but failure rates are high, particularly in syndromic cases. Some of the milder grade III and the majority of grade II knees will partially respond to casting and casting can be followed by percutaneous quadriceps recession (PQR). This has been shown to be effective and is much less invasive than a formal open release.
The underlying problem is that the quadriceps mechanism is too short in CDK. An alternative option is to perform femoral shortening osteotomy. Reports of this technique are relatively few but this is a technique that can be particularly effective for recurrent cases.
NON-OPERATIVE MANAGEMENT
Non operative management involves serial casting until 90 degrees of knee flexion is possible. At this point a Pavlik harness can be applied. This is the method of choice for Tarek grade I and grade II knees. Treatment should start within the first few days of life.
CONTRAINDICATIONS
Open release is contra indicated for knees that respond to serial casting. If it is clear that the knee is not reducing after 2-3 casts then open surgery should be considered. Radiographs in cast can be helpful in deciding whether the knee is reducing.

Surgery is performed under general anaesthetic. Caudal anaesthetic block is recommended for analgesia. The condition is generally bilateral and both knees should have surgery at the same sitting. The patient is placed in supine position. Tourniquet is not indicated since there will not be sufficient room and application of tourniquet would tether the extensor mechanism.
A single shot of broad spectrum antibiotic is administered prior to surgery and monocular diathermy should be available.

A full above knee cast should be applied. This can be difficult if there is coexisting CTEV.
Cast changes may be needed at 2 weeks to check viability of the skin. This also provides an opportunity to check that the knee remains enlocated. The urge to increase knee flexion should be avoided unless the knee is very unstable.
Total time in cast is 5-6 weeks.
DDH and CTEV frequently co exist. Ponseti casting may be trialed at the same time as casting to improve knee flexion. However, if the knee does not flex Ponseti casting is likely to fail. DDH is the newborn period is generally treated in Pavlik harness or brace but this is not possible until the knees are in flexion.
Most surgeons would address the knee deformity first followed by CTEV (Ponseti or posteromedial release) and finally DDH.

Functional results are highly dependent upon the severity of dislocation, patients with underlying conditions tending to have worse outcomes. Very few series have been published and the numbers in those published are small.
Most patients who have grade III CDK will attain a reduced joint with surgery. The majority should as a result be able to mobilise independently without aids or supports. However, a knee extensor lag is almost universal and knee flexion beyond 90 degrees is unusual from grade III cases. Patients will also often have a degree if cruciate and collateral instability, although few require further intervention.
Congenital dislocation of the knee: a protocol for management based on degree of knee flexion.
Abdelaziz TH, Samir S. J Childrens Orthopaedics. 2011; 5(2):143-149
Irreducible congenital dislocation of the knee. Aetiology and treatment.
Bell MJ, Atkins RM, Sharrard WJ. J Bone Joint Surg 1987; 69-B(3): 403-406.
Congenital hyperextension with anterior subluxation of the knee: surgical treatment and long term observations.
Curtis BH, Fisher RL. J Bone Joint Surg (Am) 1969; 51(A): 255-259.
Reference
- orthoracle.com






















